Cereno Scientific AB

Equities

CRNO B

SE0008241558

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2025-12-11 pm EST			5-day change	1st Jan Change
7.575 ^SEK	-0.85%		-5.78%	+37.73%

Dec. 09	FDA Grants Cereno Scientific Approval to Launch Phase 2b Study with CS1	FW
Dec. 08	Cereno Scientific receives FDA clearance to initiate global Phase IIb trial of CS1 in pulmonary arterial hypertension	RE

Cereno Scientific receives SEK 4 mln through exercise of warrants

Published on 11/11/2025 at 02:05 am EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Cereno Scientific AB

Dec. 09	FDA Grants Cereno Scientific Approval to Launch Phase 2b Study with CS1	FW
Dec. 08	Cereno Scientific receives FDA clearance to initiate global Phase IIb trial of CS1 in pulmonary arterial hypertension	RE
Dec. 08	Cereno Scientific AB Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension	CI
Dec. 03	Cereno Scientific to Present New Data on CS014 in Mid-December	FW
Dec. 03	Cereno Scientific AB to Present New Data of CS014 at the Pharmacology 2025 on December 15-18	CI
Dec. 01	Stockholm Bullets - VEF rises after largest holding Creditas sets sales record	FW
Dec. 01	Cereno Scientific Secures SEK 350 Million Loan Financing, Raises Additional SEK 100 Million Through Directed Share Issue	FW
Dec. 01	Cereno Scientific Secures Up to SEK350 Million Loan Financing, Launches SEK100 Million Share Issue	MT
Nov. 30	Cereno Scientific AB announces financing arrangement up to SEK 665 million with major shareholders and new investors	RE
Nov. 28	Cereno Scientific secures SEK 100 mln in directed share issue and loan financing of SEK 350 mln	RE
Nov. 27	Cereno Scientific AB announced that it expects to receive SEK 350 million in funding	CI
Nov. 27	Cereno Scientific AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 27	Cereno Scientific reports reduced operating loss	FW
Nov. 27	Cereno Scientific Q3 adjusted EPS SEK -0.07	RE
Nov. 26	Thursday, November 27 Calendar: Markets, Reports, and Key Economic Events	FW
Nov. 11	Cereno Scientific Raises SEK4 Million From Warrant Exercise	MT
Nov. 11	Cereno Scientific receives SEK 4 mln through exercise of warrants	RE
Nov. 11	Cereno Scientific Raises 4 Million SEK as Arena Investors Exercise Options	FW
Nov. 10	Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension to the U.S. FDA	CI
Nov. 10	Cereno Scientific Submits Phase 2b Study Protocol to FDA	FW
Nov. 10	Cereno Scientific submits trial protocol to U.S. FDA	RE
Sep. 21	Cereno Scientific AB(OM:CRNO B) added to S&P Global BMI Index	CI
Sep. 15	Cereno Scientific Converts SEK25 Million Convertibles to B Shares	MT
Sep. 15	Convertible Bonds in Cereno Scientific Worth SEK 25 Million Converted into Shares	FW
Aug. 27	Cereno Scientific AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI